These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27018267)

  • 1. Current Strategy for Cisplatin Delivery.
    Yue Z; Cao Z
    Curr Cancer Drug Targets; 2016; 16(6):480-8. PubMed ID: 27018267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combating the drug resistance of cisplatin using a platinum prodrug based delivery system.
    Min Y; Mao CQ; Chen S; Ma G; Wang J; Liu Y
    Angew Chem Int Ed Engl; 2012 Jul; 51(27):6742-7. PubMed ID: 22639083
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical delivery of fluorescence (6-Cf) labeled and radiolabeled (99m-Tc) cisplatin and imiquimod by a dual drug delivery system.
    Gupta V; Chuttani K; Mishra AK; Trivedi P
    J Labelled Comp Radiopharm; 2014 May; 57(6):425-33. PubMed ID: 24889134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivering a photosensitive transplatin prodrug to overcome cisplatin drug resistance.
    Song H; Li W; Qi R; Yan L; Jing X; Zheng M; Xiao H
    Chem Commun (Camb); 2015 Jul; 51(57):11493-5. PubMed ID: 26094840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Delivery Strategies for Platinum-Based Chemotherapy.
    Browning RJ; Reardon PJT; Parhizkar M; Pedley RB; Edirisinghe M; Knowles JC; Stride E
    ACS Nano; 2017 Sep; 11(9):8560-8578. PubMed ID: 28829568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel drug delivery systems for sustained and targeted delivery of anti- cancer drugs: current status and future prospects.
    Utreja P; Jain S; Tiwary AK
    Curr Drug Deliv; 2010 Apr; 7(2):152-61. PubMed ID: 20158482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotides--assembled Au nanorod-assisted cancer photothermal ablation and combination chemotherapy with targeted dual-drug delivery of Doxorubicin and Cisplatin prodrug.
    Shanmugam V; Chien YH; Cheng YS; Liu TY; Huang CC; Su CH; Chen YS; Kumar U; Hsu HF; Yeh CS
    ACS Appl Mater Interfaces; 2014 Mar; 6(6):4382-93. PubMed ID: 24559392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanodrugs based on co-delivery strategies to combat cisplatin resistance.
    Wang Q; Li H; Wu T; Yu B; Cong H; Shen Y
    J Control Release; 2024 Jun; 370():14-42. PubMed ID: 38615892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
    Zhang X; Li J; Yan M
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of carboxylate-terminated poly(amidoamine) dendrimer-mediated cisplatin formulation.
    Kulhari H; Pooja D; Singh MK; Chauhan AS
    Drug Dev Ind Pharm; 2015 Feb; 41(2):232-8. PubMed ID: 24237325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer.
    Chang CE; Hsieh CM; Chen LC; Su CY; Liu DZ; Jhan HJ; Ho HO; Sheu MT
    Drug Deliv; 2018 Nov; 25(1):632-643. PubMed ID: 29463123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances of paclitaxel formulations based on nanosystem delivery technology.
    Luo C; Wang Y; Chen Q; Han X; Liu X; Sun J; He Z
    Mini Rev Med Chem; 2012 May; 12(5):434-44. PubMed ID: 22303950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects.
    Mi Y; Zhao J; Feng SS
    Int J Pharm; 2012 Nov; 438(1-2):98-106. PubMed ID: 22954445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The latest advances of cisplatin liposomal formulations: essentials for preparation and analysis.
    Zahednezhad F; Zakeri-Milani P; Shahbazi Mojarrad J; Valizadeh H
    Expert Opin Drug Deliv; 2020 Apr; 17(4):523-541. PubMed ID: 32116060
    [No Abstract]   [Full Text] [Related]  

  • 16. Cisplatin-Induced Formation of Biocompatible and Biodegradable Polypeptide-Based Vesicles for Targeted Anticancer Drug Delivery.
    Shirbin SJ; Ladewig K; Fu Q; Klimak M; Zhang X; Duan W; Qiao GG
    Biomacromolecules; 2015 Aug; 16(8):2463-74. PubMed ID: 26166192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric drug delivery of platinum-based anticancer agents.
    Haxton KJ; Burt HM
    J Pharm Sci; 2009 Jul; 98(7):2299-316. PubMed ID: 19009590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supramolecular cisplatin-vorinostat nanodrug for overcoming drug resistance in cancer synergistic therapy.
    Xu S; Zhu X; Huang W; Zhou Y; Yan D
    J Control Release; 2017 Nov; 266():36-46. PubMed ID: 28893609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.